Call for Participation for 2016 Summit on Translational Bioinformatics

Submission Deadline: September 24, 2015, 11:59 p.m. EDT

AMIA Summits will be held between March 21 and March 24, 2016. AMIA is pleased to invite submissions for the 2016 Summit on Translational Bioinformatics (TBI), to be held March 21-22, 2016 at the Parc 55 Hotel in San Francisco, California. The Summit will be part of the Joint Summits on Translational Science and will be immediately followed by the Summit on Clinical Research Informatics (CRI) at the same venue March 23-24.

Through tutorials, lectures, panels, and posters, the 2016 TBI Summit will showcase the latest advances in bioinformatics methodology, discovery, and, increasingly, in actual clinical care through applications of personalized medicine.  There will be an invigorated effort to integrate the CRI and TBI aspects for the Joint Summits this year and a special call for submissions that have relevance to both CRI and TBI communities.  TBI and CRI will have joint programming on Tuesday, March 22 and Wednesday, March 23.

With an emphasis on cutting edge and late breaking developments, we anticipate that the TBI Summit will continue to be the premier venue for showcasing the latest bioinformatics research at the dynamic interface of biomedical research and patient care. We look forward to your submissions, which we hope will provide a rich program of cutting-edge, innovative approaches in the field of Translational Bioinformatics.

Submission Deadline: September 24, 2015, 11:59 p.m. EDT

All submissions must be made through the submission site.

Submission Categories

  • Papers
  • Student Papers
  • Podium Abstract Presentations
  • Posters
  • Panels
  • Tutorials

IMPORTANT! Submissions that do not meet the following requirements may be rejected without review: READ the submission guidelines and follow the sample format.

Learning Objectives

After participating in the AMIA 2016 Summit on Translational Bioinformatics, learners should be better able to:

  • Describe state-of-the-art informatics approaches, theories, and methods relevant to clinical and translational science
  • Apply the latest findings from research and development of informatics applications that support clinical and translational biomedical research
  • Consider possible frameworks for deploying and assessing clinical research informatics initiatives
  • Interact with professionals engaged in clinical and translational science including clinical and translational investigators, data scientists, computational biologists, genomics researchers, statistical geneticists, clinical- and bio- informaticians, public health informaticians, and those involved with clinical and research IT policy and regulatory issues
  • Explore research-related initiatives emerging from national and international clinical and translational research informatics initiatives

Target Audience

  • Biomedical and health informatics researchers and faculty
  • Bioinformaticians, statistical geneticists, molecular biologists, and physician-scientists with interest in omic data
  • Clinical and Translational Science Award (CTSA) researchers
  • Computer scientists and system developers
  • Computational biologists with interests in human disease, drug discovery, drug repurposing, and drug response
  • Genome science ethicists, lawyers, and policy experts
  • Government officials and policy makers
  • Health information and knowledge management professionals
  • HIT industry professionals and consultants
  • Industry representatives related to bioinformatics and genomics
  • Physicians, nurses, dentists, pharmacists, and other clinicians
  • Public health informaticians/practitioners, patient advocates, consumer advocates, and disease management specialists
  • Standards developers, with particular emphasis on EHR data repurposing or integration of omic data into EHRs